ARDELYX, INC.

By person

43 insiders · 447 transactions

7.8×

Michael Raab holds 7.8 times base salary in stock. $6.26M of shares against $797.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Raab last reported holding, valued at $3.86, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MOTT DAVID M

Director

$11.72M (14)

—

+$11.72M

9,914,027

3.98%

$38.24M

+85.5%

RAAB MICHAEL

President & CEO

$1.86K (1)

$8.52M (82) scheduled

−$8.52M

1,622,792

0.6512%

$6.26M

+1,955%

GRAMMER ELIZABETH A

See Remarks

$2.35K (2)

$5.16M (50) scheduled

−$5.16M

302,866

0.1215%

$1.17M

−42.0%

BASKETT FOREST

10% owner

—

$4.36M (14)

−$4.36M

21,439,656

8.60%

$82.69M

−13.5%

SANDELL SCOTT D

10% owner

—

$4.22M (12)

−$4.22M

18,849,567

7.56%

$72.70M

−15.0%

Williams Laura A

Chief Patient Officer

$1.86K (1)

$3.34M (36) scheduled

−$3.34M

367,456

0.1475%

$1.42M

+45.0%

Rosenbaum David P.

Chief Development Officer

$1.86K (1)

$2.41M (72) scheduled

−$2.41M

630,136

0.2529%

$2.43M

+139.8%

Felsch Robert Ora

See Remarks

$1.86K (1)

$1.92M (9) scheduled

−$1.92M

91,560

0.0367%

$353.14K

−5.7%

Renz Justin A

Chief Financial Officer

$1.86K (1)

$1.80M (26) scheduled

−$1.80M

409,052

0.1642%

$1.58M

+2,249%

Blanks Robert

See Remarks

—

$1.01M (30)

−$1.01M

314,421

0.1262%

$1.21M

+156.4%

Jacobs Jeffrey W

Chief Scientific Officer

—

$559.76K (14)

−$559.76K

119,483

0.0479%

$460.83K

−11.1%

Foster Eric Duane

Chief Commercial Officer

—

$277.41K (13)

−$277.41K

409,410

0.1643%

$1.58M

+7,463%

Rodriguez Susan

Chief Commercial Officer

—

$274.72K (20)

−$274.72K

449,092

0.1802%

$1.73M

+3,039%

Kelliher Mike

Chief Business Officer

—

$253.64K (12)

−$253.64K

349,660

0.1403%

$1.35M

—

Kaufmann Mark

Chief Financial Officer

—

$129.47K (4) scheduled

−$129.47K

141,418

0.0568%

$545.44K

+957.5%

Reilly Joseph James

See Remarks

—

$129.23K (8)

−$129.23K

145,854

0.0585%

$562.54K

+18.2%

Bishop John E

See Remarks

—

$109.21K (6)

−$109.21K

317,095

0.1273%

$1.22M

+45.5%

Brady James Parker

Chief Human Resources Officer

—

$84.82K (5)

−$84.82K

245,930

0.0987%

$948.53K

+48.2%

Korner Paul

EVP, Chief Medical Officer

—

$79.38K (1)

−$79.38K

72,608

0.0291%

$280.04K

+19.5%

Seeto Reginald

Chief Operating Officer

—

$52.04K (1)

−$52.04K

149,885

0.0601%

$578.09K

+8,416%

Caldwell Jeremy S

EVP, Chief Scientific Officer

—

$47.16K (2)

−$47.16K

44,497

0.0179%

$171.62K

+1,298%

RINGOLD GORDON

Director

$40.00K (1)

—

+$40.00K

35,000

0.0140%

$134.99K

+40.0%

Hohenleitner Susan

Chief Financial Officer

—

$27.01K (4)

−$27.01K

227,520

0.0913%

$877.52K

+54.9%

KERINS PATRICK J

10% owner

—

17,666,935

7.09%

$68.14M

−3.6%

BARRIS PETER J

10% owner

—

16,134,026

6.47%

$62.23M

+14.6%

BARRETT M JAMES

10% owner

—

9,169,210

3.68%

$35.36M

+4.8%

NEA Partners 12, Limited Partnership entity

10% owner

—

8,086,401

3.25%

$31.19M

−15.5%

New Enterprise Associates 12, Limited Partnership entity

10% owner

—

8,086,401

3.25%

$31.19M

−7.6%

Florence Anthony A. Jr.

10% owner

—

6,564,372

2.63%

$25.32M

+23.1%

Makhzoumi Mohamad

10% owner

—

6,564,372

2.63%

$25.32M

+6.5%

Sonsini Peter W.

10% owner

—

6,564,372

2.63%

$25.32M

+23.1%

MAKOWER JOSHUA

10% owner

—

6,564,372

2.63%

$25.32M

+23.1%

NEA 15 GP, LLC entity

10% owner

—

6,564,372

2.63%

$25.32M

+23.1%

Viswanathan Ravi

10% owner

—

6,164,372

2.47%

$23.78M

+15.6%

Sakoda Jon

10% owner

—

6,164,372

2.47%

$23.78M

+15.6%

Rodgers Richard J

Director

—

439,998

0.1766%

$1.70M

+3,795%

Bertrand William C JR

Director

—

329,507

0.1322%

$1.27M

+3,244%

Cadoret-Manier Onaiza

Director

—

178,156

0.0715%

$687.13K

—

Bhanji Muna

Director

—

163,808

0.0657%

$631.79K

—

Lundberg Jan M

Director

—

146,794

0.0589%

$566.17K

—

Parsey Merdad

Director

—

83,746

0.0336%

$323.00K

—

Bazemore Robert B

Director

—

68,006

0.0273%

$262.29K

—

Jenkins Annalisa

Director

—

33,471

0.0134%

$129.09K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

RAAB MICHAEL

15 Jul 2026

President & CEO

Sold after exercise

41,668

$5.06

$210.92K

Williams Laura A

18 Jun 2026

Chief Patient Officer

Sold after exercise

81,898

$5.99

$490.49K

RAAB MICHAEL

15 Jun 2026

President & CEO

Sold after exercise

41,666

$5.67

$236.35K

RAAB MICHAEL

15 May 2026

President & CEO

Sold after exercise

41,666

$6.28

$261.61K

RAAB MICHAEL

15 Apr 2026

President & CEO

Sold after exercise

41,668

$6.29

$261.95K

RAAB MICHAEL

16 Mar 2026

President & CEO

Sold after exercise

41,666

$5.84

$243.33K

RAAB MICHAEL

24 Feb 2026

President & CEO

Sold after exercise

41,666

$6.26

$260.62K

Williams Laura A

8 Jan 2026

Chief Patient Officer

Sold after exercise

50,000

$6.98

$348.90K

Williams Laura A

26 Aug 2025

Chief Patient Officer

Sold after exercise

30,000

$6.12

$183.63K

Williams Laura A

26 Aug 2025

Chief Patient Officer

Sold after exercise

50,000

$6.12

$306.05K

RAAB MICHAEL

2 May 2025

President & CEO

Sold after exercise

41,666

$4.25

$177.17K

RAAB MICHAEL

4 Apr 2025

President & CEO

Sold after exercise

41,666

$4.59

$191.15K

RAAB MICHAEL

7 Mar 2025

President & CEO

Sold after exercise

41,668

$5.36

$223.20K

RAAB MICHAEL

31 Jan 2025

President & CEO

Sold after exercise

41,666

$5.36

$223.35K

RAAB MICHAEL

7 Jan 2025

President & CEO

Sold after exercise

41,666

$5.31

$221.31K

RAAB MICHAEL

10 Dec 2024

President & CEO

Sold after exercise

25,000

$5.26

$131.62K

Rosenbaum David P.

6 Nov 2024

Chief Development Officer

Sold after exercise indirect

27,171

$6.10

$165.74K

Rosenbaum David P.

4 Nov 2024

Chief Development Officer

Sold after exercise indirect

27,172

$5.95

$161.67K

RAAB MICHAEL

28 Oct 2024

President & CEO

Sold after exercise

25,000

$5.91

$147.74K

RAAB MICHAEL

11 Sep 2024

President & CEO

Sold after exercise

35,000

$5.61

$196.40K

Rosenbaum David P.

20 Aug 2024

Chief Development Officer

Sold after exercise indirect

20,507

$6.00

$123.04K

RAAB MICHAEL

29 Jul 2024

President & CEO

Sold after exercise

30,000

$5.64

$169.31K

RAAB MICHAEL

13 Jun 2024

President & CEO

Sold after exercise

35,000

$6.65

$232.74K

Williams Laura A

5 Jun 2024

Chief Medical Officer

Sold after exercise

100,000

$7.13

$712.50K

Williams Laura A

5 Jun 2024

Chief Medical Officer

Sold after exercise

45,000

$7.12

$320.58K

GRAMMER ELIZABETH A

6 May 2024

See Remarks

Sold after exercise

219,937

$8.88

$1.95M

GRAMMER ELIZABETH A

6 May 2024

See Remarks

Sold after exercise

64,233

$8.87

$569.84K

Felsch Robert Ora

6 May 2024

See Remarks

Sold after exercise

55,000

$8.80

$484.00K

Felsch Robert Ora

6 May 2024

See Remarks

Sold after exercise

152,988

$8.81

$1.35M

Williams Laura A

3 May 2024

Chief Medical Officer

Sold after exercise

39,949

$8.35

$333.57K

RAAB MICHAEL

29 Apr 2024

President & CEO

Sold after exercise

30,000

$6.40

$192.06K

Renz Justin A

26 Dec 2023

Chief Financial Officer

Sold after exercise

225,000

$6.36

$1.43M

Blanks Robert

23 Jun 2023

See Remarks

Sold after exercise

33,333

$3.63

$121.04K

Showing 250 of 447 transactions. The figures above use every one of them.

By person

Individual transactions

What was left out